In the present study, we examined serum hepcidin-25 levels by liquid chromatograpy (LC)-mass spectrometry (MS)/MS and compared hepcidin mRNA expression between RCC tissues and non-neoplastic tissues from the same resected specimens by real-time reverse transcription-polymerase chain reaction (RT-PCR). The gene discussed is HAMP; the disease is renal cell carcinoma.